Clinical Trials Directory

Trials / Completed

CompletedNCT01570738

Validation of Home Sleep Testing (WP) Compared to an Overnight Sleep Testing in the Sleep Laboratory

Status
Completed
Phase
Study type
Observational
Enrollment
274 (actual)
Sponsor
Itamar-Medical, Israel · Industry
Sex
All
Age
5 Years – 90 Years
Healthy volunteers
Accepted

Summary

Obstructive sleep apnea syndrome (OSAS) is considered to be a major public health problem. The prevalence of OSAS is estimated at 2% and 4% for adult women and men respectively, most of whom are undiagnosed and untreated. The prevalence of snoring in children is high - 5% in the age group of 6 and less and about 1.5% above. The in-lab sleep study using full Polysomnography (PSG) and the manual scoring criteria set by the American Academy of Sleep Medicine was considered the gold standard for OSAS diagnosis. The high cost of in-lab full night PSG, together with long waiting lists for sleep studies, have led to the commonly used procedure of "split-night" for OSAS patients, as well as to the development of a variety of ambulatory sleep study systems. The primary study objective is to compare the efficacy of the WatchPAT (WP), as an ambulatory device for aiding in the diagnosis of sleep disorders for subjects from age 5 to 90, to the manual scoring of the PSG that serves as a "gold standard".

Conditions

Timeline

Start date
2012-07-01
Primary completion
2022-06-01
Completion
2022-06-01
First posted
2012-04-04
Last updated
2022-06-30

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT01570738. Inclusion in this directory is not an endorsement.